180 Degree Capital

180 Degree Capital is a publicly traded registered closed-end management investment company.

Business Model:

Revenue: $897.9k

Employees: 2-10

Rankings

Industries / Tags:

Detailed 180 Degree Capital Information

Geographic Data

180 Degree Capital headquarters map

Address: 1450 Broadway Fl 24

City: New York

State: NY

Zip: 10018

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

3,622,124Website Global Rank

3,682Website Monthly Traffic

Twitter Followers

Description

With some 25 tiny technology companies in our portfolio, Harris &a; Harris Group, Inc.®, is one of the most active nanotechnology investors in the world. They have funded companies developing nanoscale-enabled solutions in solid state lighting, emerging memory devices, printable electronics, material science discovery and mass-manufacturing, organic-inorganic hybrids, next-generation semiconductor devices and equipment, thermoelectric, photovoltaic and battery technologies, as well as in various life-science applications of nano-structured materials. They participate in venture capital syndicates in most of their investments, alongside top-tier venture capital firms as well as strategic (corporate) investors. Increasingly, Harris &a; Harris Group is a lead investor. They believe in the classical early stage venture capital model and disciplines and that most technology-based start-ups can use all the help they can get from the diversified experiences, Rolodexes®, complimentary business networks, technical expertise, up-to-date customer connections and financial resources that a syndicate of professional venture capital investors can provide. Harris &a; Harris Group will invest at any stage prior to a company&s;s initial public offering, and they will invest anywhere in the United States. Occasionally, they have also made private investments in publicly held companies (so-called "PIPE" investments). They have invested outside the United States, but rarely. Their current portfolio companies are distributed all across the country, plus one in Canada. Harris &a; Harris Group is looking for scientific, technological, business and execution excellence. They are attracted to markets of significant size and back passionate entrepreneurs who want to change the world with their tiny technology-enabled products. Proprietary, well-protected and highly differentiated technology is a prerequisite. But above all, they are eager to invest in companies with market-centric strategies that seek to define and dominate large product categories.

Contact Phone:
+12125820900

Contact Email:

180 Degree Capital went public on 3/25/1983 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
3/25/1983

Ticker Symbol:
TURN

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
1/2008 NanoGram Series C 0
8/2017 NGX Bio Venture Round 0
3/2012 OpGen Series C 0
4/2006 Cswitch Series B 24M
6/2011 PWA Series A 11M
9/2002 Terion Venture Round 10.8M
3/2007 Xradia Series D 7M
8/2008 Nextreme Thermal Solutions Series B 0
6/2006 SiOnyx Series A 750k
2/2008 PolyRemedy Series B 25M
3/2014 Promuc Venture Round 350k
6/2009 Solazyme Series D 11.6M
10/2007 SiOnyx Series A 10.9M
5/2011 Cobalt Technologies Series D 0
8/2011 Metabolon Series D 0
4/2006 BridgeLux Venture Round 8.5M
5/2006 Cswitch Series B 0
1/2014 Metabolon Series E 0
7/2014 NGX Bio Seed Round 500k
12/2009 Laser Light Engines Debt Financing 2M
1/2006 Metabolon Series B 0
10/2009 Metabolon Series C 0
3/2008 Metabolon Series C 0
2/2011 Nano Terra Debt Financing 750k
11/2013 EchoPixel Seed Round 2.4M
7/2014 HZO Series B 20M
12/2008 Contour Energy Series A 10.8M
11/1994 Nanophase Technologies Series D 500k
11/2009 Cambrios Technologies Series D 14.5M
4/2004 Cswitch Series A 11M
3/2005 Nextreme Thermal Solutions Series A 0
10/2009 Innovalight Venture Round 0
2/2005 Cambrios Technologies Series B 12M
11/2005 Nanosys Series C 0
11/2007 Ensemble Discovery Series B 15M
10/2011 BridgeLux Venture Round 0
8/2014 Enumeral Biomedical Post-IPO Equity 21.5M
6/2006 NeoPhotonics Series C 0
11/2005 Kovio Venture Round 10M
8/2005 Chlorogen Series B 0
3/2005 Nanomix Series C 16M
9/2007 Chlorogen Venture Round 0
4/2008 BridgeLux Series D 30M
10/2011 Contour Energy Series C 20M
2/2003 NanoGram Devices Corporation Venture Round 9.2M
1/2010 Innovalight Series D 0
10/2010 SiOnyx Series B 12.5M
9/2010 Laser Light Engines Series B 13M
5/2006 Innovalight Series B 0
3/2004 NeoPhotonics Series B 0
5/2006 D-Wave Systems Series B 14M
9/2005 Kereos Series B 0
11/2012 Nantero Series D 15M
8/2015 AgBiome Series B 0
9/2003 Nantero Series B 10.5M
3/2005 NanoOpto Series C 12M
1/2016 TARA Biosystems Seed Round 0
10/2001 Nantero Series A 6M
7/2002 Continuum Photonics Series B 14M
11/2014 AgBiome Venture Round 0
1/2008 D-Wave Systems Series C 0
10/2012 D-Wave Systems Venture Round 0
7/2012 Kovio Venture Round 7M
10/2007 Innovalight Series C 0
8/2018 Magnolia NeuroSciences Series A 0
1/2003 Optiva Series C 0
7/2018 ORIG3N Series B 0
12/2015 ORIG3N Series A 0
2/2015 ORIG3N Venture Round 3.1M
6/2000 Informio,Inc Series A 42M
9/2003 NanoOpto Series B 7M
4/2004 Molecular Imprints Series B -
6/2010 Adesto Technologies Venture Round 3.5M
9/2005 Molecular Imprints Series C 17M
6/2006 NanoOpto Series D 5M
8/2011 HZO Series B 7M
5/2008 Adesto Technologies Series A 11.5M
1/2006 NanoGram Venture Round 0
6/2004 NanoGram Series B 0
5/2008 Laser Light Engines Series A 4.5M
10/2008 Cobalt Technologies Series C 0
8/2008 Solazyme Series C 45.4M
8/2006 Crystal IS Series B 10.6M
1/2010 BridgeLux Series D 50M
11/2008 TetraVitae Bioscience Series A 6.3M
12/2009 Metabolon Series C 6M
6/2017 ORIG3N Venture Round 0
4/2004 Nanotechnologies Venture Round 10M
9/2007 Kovio Series D 19.5M
4/2013 AgBiome Series A 17.5M
6/2011 Kovio Venture Round 0
11/2005 Mersana Therapeutics Venture Round 21M
4/2004 Continuum Photonics Series C 17.5M
2/2010 Contour Energy Series B 14.2M
1/2016 Lodo Therapeutics Series A 0
3/2005 Nantero Series C 15M
3/2009 BioVex Venture Round 40M
8/2007 BridgeLux Series C 23M
10/2017 EchoPixel Series A 0
1/2016 Petra Pharma Series A 48M
12/2004 Solazyme Seed Round 310k
7/2005 NeoPhotonics Venture Round 1M
11/2013 ABSMaterials Series B 4M
9/2010 Geo Semiconductor Debt Financing 2M
8/2018 Magnolia NeuroSciences Series A 0
7/2018 ORIG3N Series B 0
10/2017 EchoPixel Series A 0
8/2017 NGX Bio Venture Round 0
6/2017 ORIG3N Venture Round 0
1/2016 Lodo Therapeutics Series A 0
1/2016 TARA Biosystems Seed Round 0
1/2016 Petra Pharma Series A 0
12/2015 ORIG3N Series A 0
8/2015 AgBiome Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research